Innovator IBD Breakout Opportunities

Goldman Sachs Increases Voting Rights in Evotec to 11.18%

Goldman Sachs Discloses 9% Stake in Umicore and Files Transparency Notice

SOLV Energy Announces Q1 2026 Earnings, Revenue Exceeds Expectations but Net Loss Widens

Ashtrom Renewable Energy Holds Groundbreaking Ceremony for El Patrimonio Solar Facility

Solv Energy released FY2025 Q1 earnings on May 12 (EST), actual revenue USD 407.85 M, actual EPS USD 0

Solv Energy released FY2026 Q1 earnings on May 12 After-Market EST, actual revenue USD 676.81 M (forecast USD 618.33 M), actual EPS USD -0.2024 (forecast USD 0.1469)

Invesco's AUM increased to $2.339 trillion in April due to market returns

Invesco Announces Managed Assets as of April 30, 2026

Goldman Sachs BDC Reports Decline in Net Asset Value in Q1

Miami released FY2026 Q1 earnings on May 6 After-Market EST, actual revenue USD 369.69 M (forecast USD 125.35 M), actual EPS USD 1.5599 (forecast USD 0.28)

Rush Street Interactive COO sells company stocks

Invesco Reports 34.7% Q1 2026 Net Income Growth, Announces Dividend and Share Repurchase

Heartland Bank & Trust Co Cut Its Stake in Goldman Sachs, Acropolis Investment Management Increased Its Holdings

Solv Energy to Release FY2026 Q1 Earnings on May 12 After-Market EST, Forecast Revenue USD 618.33 M, EPS USD 0.1469

SOLV Energy to Announce First Quarter 2026 Financial Results

Anthropico to establish a $1.5 billion joint venture with Blackstone and Goldman Sachs

Rush Street Interactive COO sells and converts company stocks

Goldman Sachs Reports 14.4% Q1 2026 Net Income Growth

Rush Street Interactive Predicts 2026 Revenue Between $1.49B and $1.54B

Miami to Release FY2026 Q1 Earnings on May 6 After-Market EST, Forecast Revenue USD 122.85 M, EPS USD 0.2925

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

BOUT

FFTY

Capital-FORCE ETF Trust has successfully transitioned the CapForce IBD® 50 ETF (FFTY) and CapForce IBD® Breakout Opportunities ETF (BOUT) to its new rules-based ETF platform. This move aims to enhance marketing and operational efficiencies, positioning these funds for future growth. CEO Mark MacArthur emphasized the integration of IBD's research methodology into the ETF structure, which is designed to help investors navigate market cycles. The existing ticker symbols are retained, but the funds will now reflect the CapForce branding.

StockTitan

Innovator IBD 50

Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform | BOUT Stock News

Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs | BOUT Stock News

Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs | BOUT Stock News

After landing a spot on the list of new buys by top funds, Esco stock pops onto the IBD Breakout Stocks Index.

Esco Tech

US Navy partner in stealth technology targets breakout in murky market

Innovator IBD Breakout Opportunities(BOUT.US)

Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform | BOUT Stock News

Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs | BOUT Stock News

US Navy partner in stealth technology targets breakout in murky market